京新药业(002020.SZ)累计回购5.49%股份 耗资6.09亿元

Group 1 - The company, Jingxin Pharmaceutical (002020.SZ), announced a share repurchase plan, intending to buy back 47.271295 million shares, which represents 5.49% of its total share capital [1] - The total amount for the share repurchase is set at 609 million yuan, excluding transaction fees [1]